References

Abdelgadir EI, Hafidh K, Basheir AM Comparison of incidences, hospital stay and precipitating factors of diabetic ketoacidosis in Ramadan and the following month in three major hospitals in United Arab Emigrates. A prospective observational study. J Diabetes Metab.. 2015; 6

Al Sifri S, Basiounny A, Echtay A, Al Omari M, Harman-Boehm I, Kaddaha G, Al Tayeb K, Mahfouz AS, Al Elq A, Radican L The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial. Int J Clin Pract.. 2011; 65:(11)1132-1140 https://doi.org/10.1111/j.1742-1241.2011.02797.x

Anwar A, Azmi KN, Hamidon BB, Khalid BA. An open label comparative study of glimepiride versus repaglinide in type 2 diabetes mellitus Muslim subjects during the month of Ramadan. Med J Malaysia. 2006; 61:(1)28-35

Al-Arouj M, Assaad-Khalil S, Buse J Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care. 2010; 33:(8)1895-1902 https://doi.org/10.2337/dc10-0896

Al-Arouj M, Hassoun AAK, Medlej R The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study. Int J Clin Pract.. 2013; 67:(10)957-963 https://doi.org/10.1111/ijcp.12243

qAravind SR, Tayeb KA, Ismail SB Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study. Curr Med Res Opin.. 2011; 27:(6)1237-1242 https://doi.org/10.1185/03007995.2011.578245

Aravind SR, Ismail SB, Balamurugan R Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Curr Med Res Opin.. 2012; 28:(8)1289-1296 https://doi.org/10.1185/03007995.2012.707119

Azar ST, Echtay A, Wan Bebakar WM Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): a randomized trial. Diabetes Obes Metab.. 2016; 18:(10)1025-1033 https://doi.org/10.1111/dom.12733

Babineaux SM, Toaima D, Boye KS Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med.. 2015; 32:(6)819-828 https://doi.org/10.1111/dme.12685

Benbarka MM, Khalil AB, Beshyah SA, Marjei S, Awad SA. Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report. Diabetes Technol Ther. 2010; 12:(4)287-290 https://doi.org/10.1089/dia.2009.0130

Brady EM, Davies MJ, Gray LJ A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial. Diabetes Obes Metab. 2014; 16:(6)527-536 https://doi.org/10.1111/dom.12249

Bravis V, Hui E, Salih S, Mehar S, Hassanein M, Devendra D. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan. Diabet Med. 2010; 27:(3)327-331 https://doi.org/10.1111/j.1464-5491.2010.02948.x

Diabetes UK. Managing diabetes during Ramadan. 2017. http://www.diabetes.org.uk/resources-s32017-09/09/1118A_Ramadan%20Factsheet_update_April2017_amended.pdf (accessed 10 March 2020)

Fralick M, Schneeweiss S, Patorno E. Risk of diabetic ketoacidosis after initiation of an SGLT-2 inhibitor. N Engl J Med. 2017; 376:(23)2300-2302 https://doi.org/10.1056/NEJMc1701990

Hassanein M, Abdallah K, Schweizer A. A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study. Vasc Health Risk Manag.. 2014; 10:319-326

Diabetes and Ramadan: Practical Guidelines. 2016. http://www.idf.org/guidelines/diabetes-in-ramadan (accessed 10 March 2020)

Hassanein M, Al-Arouj M, Hamdy O Diabetes and Ramadan: practical guidelines. Diabetes Res Clin Pract.. 2017; 126:303-316 https://doi.org/10.1016/j.diabres.2017.03.003

Kadiri A, Al-Nakhi A, El-Ghazali S Treatment of type 1 diabetes with insulin lispro during Ramadan. Diabetes Metab.. 2001; 27:(4 Pt 1)482-486

Moolla A, Khalid N, Chowdhery T. Diabetes and Ramadan. British Journal of Family Medicine. 2013; 1:19-20

Muslim Council of Britain Advisory Group and Diabetes UK. Managing Diabetes during Ramadan. 2014. https://mcb.org.uk/wp-content/uploads/2014/06/Ramadan-Factsheet-English-2015-9_3_15.pdf (accessed 10 March 2020)

Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycaemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose co-transporter-2 inhibitors. Diabetes Care. 2015; 38:(9)1687-1693 https://doi.org/10.2337/dc15-0843

Salti I, Benard E, Detournay P A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries. The EPIDIAR study. Diabetes Care. 2004; 27:2306-2311 https://doi.org/10.2337/diacare.27.10.2306

Sari R, Balci MK, Akbas SH, Avci B. The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res. 2004; 30:(2)169-177 https://doi.org/10.1081/ERC-200027375

Wan Seman WJ, Kori N Switching from sulphonylurea to a sodium-glucose cotransporter2 inhibitor in the fasting month of Ramadan is associated with a reduction in hypoglycaemia. Diabetes Obes Metab. 2016; 18:(6)628-632 https://doi.org/10.1111/dom.12649

Managing diabetes in primary care during Ramadan

02 April 2020
Volume 31 · Issue 4

Abstract

Individuals with diabetes may wish to fast during the holy month of Ramadan. David Morris provides an overview of the key considerations for practice nurses helping people with diabetes to manage their condition

Ramadan is the holiest month of the Islamic calendar, during which healthy adult Muslims fast. Vulnerable people with diabetes can be exempted from fasting during Ramadan; however, many Muslims with diabetes feel strongly committed to observing Ramadan. The adoption of fasting together with alteration of mealtimes, sleeping arrangements and exercise, places physiological demands on the individual that are likely to be greater in those with diabetes. Health professionals involved in the care of these patients need to offer timely advice on the risks associated with fasting in those with diabetes and, where fasting is planned, support and empower these individuals.

Ramadan is the holiest month of the Islamic calendar, during which there is an obligation for healthy adult Muslims to fast (Moolla et al, 2013). The period of fasting continues for 30 days, commencing at sunrise and continuing until sunset, and includes abstinence from both food and drink. Usually two meals per 24 hours are eaten, one pre-dawn (Suhoor) and one post-sunset (Iftar). Fasting is believed to bring spiritual, psychological and physical benefits. The dates of Ramadan are based on the lunar calendar and advance 10 to 11 days each (solar) year. This year in the UK, Ramadan commences after sunset on Thursday 23 April and ends at sundown on Saturday 23 May.

The adoption of fasting together with alteration of mealtimes, sleeping arrangements and exercise, places physiological demands on the individual that are likely to be greater in those with diabetes (Hassanein et al, 2017). This article looks at the challenges faced by people with diabetes during Ramadan and how these individuals can best be advised to manage their diabetes during this period.

Register now to continue reading

Thank you for visiting Practice Nursing and reading some of our peer-reviewed resources for general practice nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month